DeBolt Chelsea A, Sarker Minhazur, Cohen Natalie, Kaplowitz Elianna, Buckley Ayisha, Stone Joanne, Bianco Angela
Department of Obstetrics, Gynecology & Reproductive Science, Mount Sinai Health System & Icahn School of Medicine at Mount Sinai, New York, NY, United States.
Department of Obstetrics, Gynecology & Reproductive Science, Mount Sinai Health System & Icahn School of Medicine at Mount Sinai, New York, NY, United States.
Eur J Obstet Gynecol Reprod Biol. 2022 May;272:1-5. doi: 10.1016/j.ejogrb.2022.03.003. Epub 2022 Mar 5.
To determine if early-onset fetal growth restriction with abnormal individual biometric parameters, defined as head circumference, abdominal circumference and femur length less than the 10th percentile, is associated with adverse neonatal outcomes compared to fetal growth restriction with normal biometric parameters.
Retrospective cohort study including women diagnosed with fetal growth restriction between 16 and 24 weeks gestation who delivered a singleton, non-anomalous neonate at Mount Sinai Hospital from 2013 to 2019. The primary outcome was rate of small for gestational age neonate at delivery. Maternal, obstetric and neonatal outcomes were compared using multivariable regression analysis.
Patients diagnosed with fetal growth restriction with abnormal biometric parameters were more likely to be nulliparous, diagnosed with severe growth restriction and to receive antenatal corticosteroids than those with normal biometric parameters. The rate of small for gestational age neonate at delivery was higher in those with abnormal parameters (OR 4.0, 95% CI 1.7-9.2, p < 0.01) when compared to normal parameters. The rate of resolution of fetal growth restriction was higher in the normal biometric parameter group compared to those with abnormal parameters (OR 3.3, 95% CI 1.4-8.1, p < 0.01).
Fetal growth restriction and normal biometric parameters diagnosed at second trimester ultrasound is associated with an increased likelihood of resolution of growth restriction and decreased likelihood of delivering a small for gestational age neonate.
确定个体生物测量参数异常(定义为头围、腹围和股骨长度小于第10百分位数)的早发型胎儿生长受限与生物测量参数正常的胎儿生长受限相比,是否与不良新生儿结局相关。
回顾性队列研究,纳入2013年至2019年在西奈山医院诊断为胎儿生长受限、孕周在16至24周之间且分娩单胎、无畸形新生儿的孕妇。主要结局指标是分娩时小于胎龄儿的发生率。使用多变量回归分析比较母体、产科和新生儿结局。
与生物测量参数正常的患者相比,诊断为生物测量参数异常的胎儿生长受限患者更有可能为初产妇、被诊断为严重生长受限并接受产前皮质类固醇治疗。与参数正常的患者相比,参数异常的患者分娩时小于胎龄儿的发生率更高(OR 4.0,95%CI 1.7 - 9.2,p < 0.01)。生物测量参数正常组胎儿生长受限的缓解率高于参数异常组(OR 3.3,95%CI 1.4 - 8.1,p < 0.01)。
孕中期超声诊断的胎儿生长受限且生物测量参数正常与生长受限缓解的可能性增加以及分娩小于胎龄儿的可能性降低相关。